FDA Cybersecurity Deficiency Letter Examples & Analysis

Analyze real-world FDA cybersecurity deficiency letter examples. Learn how to address RTA and AI deficiency requests for 510(k) and PMA submissions.

This guide is written for medical device manufacturers navigating FDA cybersecurity deficiency letter examples. It is built from real submissions, FDA correspondence, and the standards reviewers actually cite. Use it as a working reference: read straight through, jump to the section that matches your current gap, or hand it to your engineering and regulatory leads as a checklist.

Introduction to FDA Cybersecurity Deficiencies

Introduction to FDA Cybersecurity Deficiencies is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

The Shift Since Section 524B of the FD&C Act

The Shift Since Section 524B of the FD&C Act — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

RTA (Refuse to Accept) vs. Substantive Interaction Deficiencies

RTA (Refuse to Accept) vs. Substantive Interaction Deficiencies — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Common Cybersecurity Deficiency Categories

Common Cybersecurity Deficiency Categories is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Example 1: Software Bill of Materials (SBOM) Gaps

Example 1: Software Bill of Materials (SBOM) Gaps — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Example 2: Incomplete Threat Modeling (STRIDE/TARA)

Example 2: Incomplete Threat Modeling (STRIDE/TARA) — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Example 3: Lack of Traceability in Security Requirements

Example 3: Lack of Traceability in Security Requirements — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Detailed Analysis: Deficiency Letter Examples

Detailed Analysis: Deficiency Letter Examples is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Sample Deficiency: Insufficient Penetration Testing Coverage

Sample Deficiency: Insufficient Penetration Testing Coverage — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Sample Deficiency: Vulnerability Management Postmarket Plans

Sample Deficiency: Vulnerability Management Postmarket Plans — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Sample Deficiency: Unverified Third-Party Software (SOUP) Security

Sample Deficiency: Unverified Third-Party Software (SOUP) Security — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

How to Respond to a Deficiency Letter (AIs)

How to Respond to a Deficiency Letter (AIs) is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

The 'Stop the Clock' Impact on Timeline

The 'Stop the Clock' Impact on Timeline — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Structuring Your Response and Objective Evidence

Structuring Your Response and Objective Evidence — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Avoiding Deficiencies: The SPDF Approach

Avoiding Deficiencies: The SPDF Approach is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Frequently asked questions

How do I respond to an FDA cybersecurity deficiency letter?

Short answer: Treat it as a process, not a one-off document: own the requirement in design controls, map it to a current standard, generate evidence during V&V, and surface the residual risk in your postmarket plan. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

What are the most common reasons for FDA cybersecurity holds?

Short answer: FDA cybersecurity deficiency letter examples is a discrete deliverable inside the Secure Product Development Framework (SPDF). FDA expects it documented, traceable, and version-controlled inside your QMS. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

Does a deficiency letter mean my 510(k) will be rejected?

Short answer: Yes — under Section 524B and the February 2026 final guidance, every cyber device requires the artifact in question. Skipping it is the fastest way to an RTA hold. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

What does the FDA require for SBOM in a deficiency response?

Short answer: FDA cybersecurity deficiency letter examples is a discrete deliverable inside the Secure Product Development Framework (SPDF). FDA expects it documented, traceable, and version-controlled inside your QMS. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

How much time do I have to answer FDA cybersecurity AIs?

Short answer: FDA gives sponsors 180 days to respond to a Major deficiency / AI letter (15 days for an RTA hold). Plan for two iteration cycles; teams that ship a clean response in one round are the ones with a working SPDF. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

Where this fits in the cluster

This page sits downstream of our pillar resources on FDA cybersecurity deficiency letter examples. If you arrived here from a different starting point, these are the most useful adjacent pages:

• FDA Cybersecurity Deficiency Response
• 12 Reasons the FDA Rejects Medical Device Cybersecurity Submissions
• FDA Cybersecurity Deficiency Letter Response Checklist
• The SPDF Playbook for FDA-Ready Medical Devices

Related from Blue Goat Cyber

• FDA Premarket Cybersecurity Services
• Medical Device Threat Modeling
• FDA-Compliant SBOM Services
• Medical Device Penetration Testing
• 12 Critical Threat Modeling Gaps in Medical Device Submissions

Sources & primary references

• Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions — U.S. Food and Drug Administration (FDA)
• Postmarket Management of Cybersecurity in Medical Devices — U.S. Food and Drug Administration (FDA)
• Secure Software Development Framework (SSDF) Version 1.1 — NIST
• Principles and Practices for Medical Device Cybersecurity — International Medical Device Regulators Forum (IMDRF)

Talk to a regulatory cybersecurity team

If you are working through FDA cybersecurity deficiency letter examples and want a second pair of eyes on your submission package, we ship cybersecurity deliverables for medical device manufacturers across 510(k), De Novo, PMA, and EU MDR pathways. Book a discovery session and we will walk your evidence with you.